SIMILAR PATTERNS OF AMINO ACIDS FOR 2VCD_A_RAPA138

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fd9 PROTEIN (MACROPHAGE
INFECTIVITY
POTENTIATOR PROTEIN)


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
5 TYR A 131
ASP A 142
PHE A 153
GLN A 154
TRP A 162
None
1.30A 2vcdA-1fd9A:
20.3
2vcdA-1fd9A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fd9 PROTEIN (MACROPHAGE
INFECTIVITY
POTENTIATOR PROTEIN)


(Legionella
pneumophila)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
10 TYR A 131
PHE A 141
ASP A 142
PHE A 153
GLN A 157
VAL A 158
ILE A 159
PRO A 160
TRP A 162
TYR A 185
None
0.93A 2vcdA-1fd9A:
20.3
2vcdA-1fd9A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fkk FK506 BINDING
PROTEIN


(Bos taurus)
PF00254
(FKBP_C)
7 TYR A  26
PHE A  36
ASP A  37
VAL A  55
ILE A  56
TRP A  59
TYR A  82
None
0.98A 2vcdA-1fkkA:
13.6
2vcdA-1fkkA:
35.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
6 TYR A  92
PHE A 102
ASP A 103
ILE A 120
TRP A 123
TYR A 146
None
1.02A 2vcdA-1jvwA:
18.4
2vcdA-1jvwA:
40.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
6 TYR A  92
PHE A 102
PHE A 114
ILE A 120
TRP A 123
TYR A 146
None
0.98A 2vcdA-1jvwA:
18.4
2vcdA-1jvwA:
40.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1jvw MACROPHAGE
INFECTIVITY
POTENTIATOR


(Trypanosoma
cruzi)
PF00254
(FKBP_C)
6 TYR A  92
PHE A 114
VAL A 119
ILE A 120
TRP A 123
TYR A 146
None
0.78A 2vcdA-1jvwA:
18.4
2vcdA-1jvwA:
40.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kt1 FK506-BINDING
PROTEIN FKBP51


(Saimiri
boliviensis)
PF00254
(FKBP_C)
PF00515
(TPR_1)
PF13181
(TPR_8)
5 TYR A  57
GLN A  85
VAL A  86
ILE A  87
TRP A  90
None
1.30A 2vcdA-1kt1A:
13.7
2vcdA-1kt1A:
12.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1n1a FKBP52

(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  57
PHE A  67
ASP A  68
VAL A  86
ILE A  87
TRP A  90
TYR A 113
None
0.83A 2vcdA-1n1aA:
14.3
2vcdA-1n1aA:
33.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pbk FKBP25

(Homo sapiens)
PF00254
(FKBP_C)
6 TYR A 135
PHE A 145
ASP A 146
VAL A 171
ILE A 172
TRP A 175
RAP  A 225 (-3.9A)
RAP  A 225 (-4.6A)
RAP  A 225 (-3.0A)
RAP  A 225 (-3.5A)
RAP  A 225 (-3.9A)
RAP  A 225 (-3.4A)
0.75A 2vcdA-1pbkA:
13.4
2vcdA-1pbkA:
31.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1pbk FKBP25

(Homo sapiens)
PF00254
(FKBP_C)
6 TYR A 135
PHE A 145
VAL A 171
ILE A 172
TRP A 175
TYR A 198
RAP  A 225 (-3.9A)
RAP  A 225 (-4.6A)
RAP  A 225 (-3.5A)
RAP  A 225 (-3.9A)
RAP  A 225 (-3.4A)
RAP  A 225 (-4.6A)
0.94A 2vcdA-1pbkA:
13.4
2vcdA-1pbkA:
31.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA


(Escherichia
coli)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
6 PHE A 156
ASP A 157
PHE A 168
ILE A 174
TRP A 177
TYR A 200
None
1.35A 2vcdA-1q6hA:
19.5
2vcdA-1q6hA:
37.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q6h FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKPA


(Escherichia
coli)
PF00254
(FKBP_C)
PF01346
(FKBP_N)
8 TYR A 146
PHE A 156
ASP A 157
VAL A 173
ILE A 174
PRO A 175
TRP A 177
TYR A 200
None
1.05A 2vcdA-1q6hA:
19.5
2vcdA-1q6hA:
37.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r4a ADP-RIBOSYLATION
FACTOR-LIKE PROTEIN
1


(Rattus
norvegicus)
PF00025
(Arf)
5 TYR A  81
PHE A  51
VAL A  53
TRP A  66
VAL A  91
None
1.39A 2vcdA-1r4aA:
undetectable
2vcdA-1r4aA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r9h FK506 BINDING
PROTEIN FAMILY


(Caenorhabditis
elegans)
PF00254
(FKBP_C)
7 TYR A  40
PHE A  50
ASP A  51
VAL A  69
ILE A  70
TRP A  73
TYR A  96
None
0.93A 2vcdA-1r9hA:
14.7
2vcdA-1r9hA:
28.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r9h FK506 BINDING
PROTEIN FAMILY


(Caenorhabditis
elegans)
PF00254
(FKBP_C)
5 TYR A  40
PHE A  50
PHE A  60
TRP A  73
TYR A  96
None
1.37A 2vcdA-1r9hA:
14.7
2vcdA-1r9hA:
28.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s0p ADENYLYL
CYCLASE-ASSOCIATED
PROTEIN


(Dictyostelium
discoideum)
PF01213
(CAP_N)
5 TYR A 194
GLN A  83
VAL A  85
ILE A  88
VAL A 152
None
1.18A 2vcdA-1s0pA:
undetectable
2vcdA-1s0pA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u79 FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
3


(Arabidopsis
thaliana)
PF00254
(FKBP_C)
7 TYR A  37
PHE A  47
ASP A  48
VAL A  66
ILE A  67
TRP A  70
TYR A  99
None
0.93A 2vcdA-1u79A:
13.9
2vcdA-1u79A:
33.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u84 HYPOTHETICAL PROTEIN

(Geobacillus
stearothermophilus)
PF08958
(DUF1871)
5 TYR A  27
ASP A  18
PHE A  59
ILE A  63
PRO A  64
None
1.38A 2vcdA-1u84A:
undetectable
2vcdA-1u84A:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1we5 PUTATIVE FAMILY 31
GLUCOSIDASE YICI


(Escherichia
coli)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
5 TYR A 662
ASP A 642
PHE A 628
GLN A 627
VAL A 626
None
1.23A 2vcdA-1we5A:
undetectable
2vcdA-1we5A:
10.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1yat FK506 BINDING
PROTEIN


(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
7 TYR A  26
PHE A  36
ASP A  37
VAL A  55
ILE A  56
TRP A  59
TYR A  82
FK5  A 108 ( 4.0A)
FK5  A 108 ( 4.8A)
FK5  A 108 ( 3.3A)
FK5  A 108 ( 3.4A)
FK5  A 108 ( 3.7A)
FK5  A 108 ( 3.6A)
FK5  A 108 ( 4.7A)
0.91A 2vcdA-1yatA:
15.0
2vcdA-1yatA:
31.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yga HYPOTHETICAL 37.9
KDA PROTEIN IN
BIO3-HXT17
INTERGENIC REGION


(Saccharomyces
cerevisiae)
PF01263
(Aldose_epim)
5 TYR A 338
PHE A 179
GLN A  44
VAL A  42
VAL A  12
None
1.13A 2vcdA-1ygaA:
undetectable
2vcdA-1ygaA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a7n L(+)-MANDELATE
DEHYDROGENASE


(Pseudomonas
putida;
Spinacia
oleracea)
PF01070
(FMN_dh)
5 PHE A 287
ASP A 292
PHE A  49
GLN A 354
PRO A 350
None
1.36A 2vcdA-2a7nA:
undetectable
2vcdA-2a7nA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bk9 CG9734-PA

(Drosophila
melanogaster)
PF00042
(Globin)
5 PHE A 143
PHE A  31
VAL A 112
TYR A 139
VAL A 138
None
HEM  A1154 ( 3.9A)
None
None
None
1.12A 2vcdA-2bk9A:
undetectable
2vcdA-2bk9A:
24.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2frg TREM-LIKE
TRANSCRIPT-1


(Homo sapiens)
no annotation 5 TYR P 102
ASP P  98
GLN P  88
VAL P  36
ILE P  34
None
1.46A 2vcdA-2frgP:
undetectable
2vcdA-2frgP:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2in3 HYPOTHETICAL PROTEIN

(Nitrosomonas
europaea)
PF01323
(DSBA)
5 ASP A 139
VAL A 127
ILE A 116
PRO A  14
VAL A 101
None
1.44A 2vcdA-2in3A:
undetectable
2vcdA-2in3A:
23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgp TYROCIDINE
SYNTHETASE 3


(Brevibacillus
brevis)
PF00550
(PP-binding)
PF00668
(Condensation)
5 PHE A 501
PHE A 392
GLN A 394
ILE A 508
PRO A 512
None
1.33A 2vcdA-2jgpA:
undetectable
2vcdA-2jgpA:
14.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2pbc FK506-BINDING
PROTEIN 2


(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  56
PHE A  66
ASP A  67
VAL A  85
ILE A  86
TRP A  89
TYR A 112
PEG  A 201 (-4.4A)
None
None
PEG  A 201 (-3.6A)
PEG  A 201 (-3.8A)
PEG  A 201 (-3.7A)
None
0.86A 2vcdA-2pbcA:
10.6
2vcdA-2pbcA:
35.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rhq PHENYLALANYL-TRNA
SYNTHETASE BETA
CHAIN


(Staphylococcus
haemolyticus)
PF01588
(tRNA_bind)
PF03147
(FDX-ACB)
PF03483
(B3_4)
PF03484
(B5)
5 ASP B  10
GLN B 162
VAL B 163
ILE B   3
VAL B 185
None
1.43A 2vcdA-2rhqB:
undetectable
2vcdA-2rhqB:
10.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn1 70 KDA
PEPTIDYLPROLYL
ISOMERASE


(Plasmodium
falciparum)
PF00254
(FKBP_C)
6 TYR A  44
PHE A  55
ASP A  56
VAL A  74
ILE A  75
TRP A  78
FK5  A 501 (-4.1A)
FK5  A 501 (-4.5A)
FK5  A 501 (-3.4A)
FK5  A 501 (-3.5A)
FK5  A 501 (-4.3A)
FK5  A 501 (-3.3A)
0.76A 2vcdA-2vn1A:
14.6
2vcdA-2vn1A:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn1 70 KDA
PEPTIDYLPROLYL
ISOMERASE


(Plasmodium
falciparum)
PF00254
(FKBP_C)
5 TYR A  44
VAL A  74
ILE A  75
TRP A  78
TYR A 101
FK5  A 501 (-4.1A)
FK5  A 501 (-3.5A)
FK5  A 501 (-4.3A)
FK5  A 501 (-3.3A)
FK5  A 501 (-4.7A)
0.75A 2vcdA-2vn1A:
14.6
2vcdA-2vn1A:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2we5 CARBAMATE KINASE 1

(Enterococcus
faecalis)
PF00696
(AA_kinase)
5 ASP A 120
GLN A 113
VAL A 114
ILE A 207
VAL A 161
None
1.40A 2vcdA-2we5A:
undetectable
2vcdA-2we5A:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ww2 ALPHA-1,2-MANNOSIDAS
E


(Bacteroides
thetaiotaomicron)
PF07971
(Glyco_hydro_92)
5 TYR A  98
ASP A 349
PHE A 258
GLN A 263
VAL A  55
None
1.44A 2vcdA-2ww2A:
undetectable
2vcdA-2ww2A:
11.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x24 ACETYL-COA
CARBOXYLASE


(Bos taurus)
PF01039
(Carboxyl_trans)
5 PHE A 469
ASP A 468
VAL A 319
TRP A 334
VAL A 408
None
1.25A 2vcdA-2x24A:
undetectable
2vcdA-2x24A:
10.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
5 TYR A  33
ASP A  44
ILE A  63
TRP A  66
TYR A  89
None
0.91A 2vcdA-2y78A:
15.2
2vcdA-2y78A:
34.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
5 TYR A  33
PHE A  43
ASP A  44
ILE A  63
TRP A  66
None
0.90A 2vcdA-2y78A:
15.2
2vcdA-2y78A:
34.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
5 TYR A  33
PHE A  43
VAL A  62
ILE A  63
TRP A  66
None
0.75A 2vcdA-2y78A:
15.2
2vcdA-2y78A:
34.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y78 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
5 TYR A  33
VAL A  62
ILE A  63
TRP A  66
TYR A  89
None
0.81A 2vcdA-2y78A:
15.2
2vcdA-2y78A:
34.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zsj THREONINE SYNTHASE

(Aquifex
aeolicus)
PF00291
(PALP)
5 PHE A 201
VAL A 188
ILE A 186
PRO A 187
VAL A 314
None
PLP  A1101 (-4.0A)
None
None
None
1.36A 2vcdA-2zsjA:
undetectable
2vcdA-2zsjA:
17.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c75 METHYLAMINE
DEHYDROGENASE HEAVY
CHAIN


(Paracoccus
versutus)
PF06433
(Me-amine-dh_H)
5 PHE H 246
PHE H 272
GLN H 179
ILE H 224
VAL H 205
None
1.41A 2vcdA-3c75H:
undetectable
2vcdA-3c75H:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h5t TRANSCRIPTIONAL
REGULATOR, LACI
FAMILY


(Corynebacterium
glutamicum)
PF00356
(LacI)
PF13377
(Peripla_BP_3)
5 TYR A 135
ASP A 158
GLN A  97
VAL A  95
VAL A 345
None
1.15A 2vcdA-3h5tA:
undetectable
2vcdA-3h5tA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hmj FATTY ACID SYNTHASE
SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00109
(ketoacyl-synt)
PF01648
(ACPS)
PF02801
(Ketoacyl-synt_C)
5 ASP A 764
VAL A 822
ILE A 768
PRO A 770
VAL A 703
None
1.30A 2vcdA-3hmjA:
undetectable
2vcdA-3hmjA:
6.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3krb ALDOSE REDUCTASE

(Giardia
intestinalis)
PF00248
(Aldo_ket_red)
5 TYR A  40
ASP A  35
VAL A  19
ILE A  46
VAL A  66
UNX  A 402 (-4.4A)
NAP  A 400 (-3.7A)
None
None
None
1.41A 2vcdA-3krbA:
undetectable
2vcdA-3krbA:
18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l9d PUTATIVE GTP
PYROPHOSPHOKINASE


(Streptococcus
mutans)
PF04607
(RelA_SpoT)
5 ASP A  96
GLN A 101
VAL A 119
ILE A 138
VAL A  14
None
1.28A 2vcdA-3l9dA:
undetectable
2vcdA-3l9dA:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n91 UNCHARACTERIZED
PROTEIN


(Bacteroides
ovatus)
PF08522
(DUF1735)
5 GLN A 158
VAL A  80
ILE A 120
PRO A 121
VAL A 129
None
1.22A 2vcdA-3n91A:
undetectable
2vcdA-3n91A:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5d PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  57
PHE A  67
ASP A  68
VAL A  86
ILE A  87
TRP A  90
TYR A 113
None
1.01A 2vcdA-3o5dA:
14.2
2vcdA-3o5dA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5e PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
PHE A  67
ASP A  68
ILE A  87
TYR A 113
None
0.82A 2vcdA-3o5eA:
14.8
2vcdA-3o5eA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5e PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
VAL A  86
ILE A  87
TRP A  90
TYR A 113
None
0.77A 2vcdA-3o5eA:
14.8
2vcdA-3o5eA:
27.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pa7 70 KDA
PEPTIDYLPROLYL
ISOMERASE, PUTATIVE


(Plasmodium
vivax)
PF00254
(FKBP_C)
7 TYR A  43
PHE A  54
ASP A  55
VAL A  73
ILE A  74
TRP A  77
TYR A 100
None
0.86A 2vcdA-3pa7A:
14.7
2vcdA-3pa7A:
32.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pa7 70 KDA
PEPTIDYLPROLYL
ISOMERASE, PUTATIVE


(Plasmodium
vivax)
PF00254
(FKBP_C)
5 TYR A  43
PHE A  54
PHE A  64
TRP A  77
TYR A 100
None
1.35A 2vcdA-3pa7A:
14.7
2vcdA-3pa7A:
32.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vsv XYLOSIDASE

(Thermoanaerobacterium
saccharolyticum)
PF13229
(Beta_helix)
5 TYR A 411
PHE A 475
ASP A 473
VAL A 402
VAL A 489
None
1.30A 2vcdA-3vsvA:
undetectable
2vcdA-3vsvA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aut DECAPRENYL-PHOSPHORY
L-BETA-D-RIBOFURANOS
E-2-OXIDOREDUCTASE


(Mycolicibacterium
smegmatis)
PF01565
(FAD_binding_4)
PF04030
(ALO)
5 PHE A 457
PHE A  14
VAL A  42
ILE A  43
PRO A  40
None
1.31A 2vcdA-4autA:
undetectable
2vcdA-4autA:
16.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4bf8 FPR4

(Saccharomyces
cerevisiae)
PF00254
(FKBP_C)
6 TYR A 313
PHE A 323
ASP A 324
VAL A 341
ILE A 342
TRP A 345
None
0.88A 2vcdA-4bf8A:
14.2
2vcdA-4bf8A:
30.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dvh SUPEROXIDE DISMUTASE

(Trypanosoma
cruzi)
PF00081
(Sod_Fe_N)
PF02777
(Sod_Fe_C)
5 PHE A  20
PHE A 115
VAL A 116
TRP A 185
TYR A 180
None
1.45A 2vcdA-4dvhA:
undetectable
2vcdA-4dvhA:
20.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4dz3 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
6 TYR A  33
PHE A  43
ASP A  44
VAL A  62
ILE A  63
TRP A  66
FK5  A 201 ( 3.9A)
FK5  A 201 (-4.8A)
FK5  A 201 (-3.5A)
FK5  A 201 ( 3.6A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.4A)
0.82A 2vcdA-4dz3A:
15.2
2vcdA-4dz3A:
34.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4dz3 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei)
PF00254
(FKBP_C)
6 TYR A  33
PHE A  43
VAL A  62
ILE A  63
TRP A  66
TYR A  89
FK5  A 201 ( 3.9A)
FK5  A 201 (-4.8A)
FK5  A 201 ( 3.6A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.4A)
FK5  A 201 (-4.7A)
0.90A 2vcdA-4dz3A:
15.2
2vcdA-4dz3A:
34.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4el1 PROTEIN
DISULFIDE-ISOMERASE


(Homo sapiens)
PF00085
(Thioredoxin)
PF13848
(Thioredoxin_6)
5 PHE A 249
PHE A 275
VAL A 237
ILE A 238
PRO A 235
None
1.39A 2vcdA-4el1A:
undetectable
2vcdA-4el1A:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iqc PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B


(Homo sapiens)
PF00254
(FKBP_C)
5 PHE A  36
ASP A  37
GLN A  53
ILE A  56
TYR A  82
None
1.34A 2vcdA-4iqcA:
13.6
2vcdA-4iqcA:
29.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iqc PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  26
PHE A  36
ASP A  37
ILE A  56
TYR A  82
None
0.95A 2vcdA-4iqcA:
13.6
2vcdA-4iqcA:
29.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4


(Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  57
PHE A  67
ASP A  68
VAL A  86
ILE A  87
TRP A  90
TYR A 113
None
None
None
DMS  A 304 (-3.5A)
DMS  A 304 (-3.8A)
DMS  A 304 ( 4.0A)
None
0.80A 2vcdA-4lawA:
14.0
2vcdA-4lawA:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4law PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP4


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
PHE A  67
PHE A  77
TRP A  90
TYR A 113
None
None
None
DMS  A 304 ( 4.0A)
None
1.29A 2vcdA-4lawA:
14.0
2vcdA-4lawA:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lhu 9C2 TCR DELTA CHAIN
9C2 TCR GAMMA CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 ASP D 164
GLN G 182
VAL D 168
ILE D 167
VAL D 193
None
1.38A 2vcdA-4lhuD:
undetectable
2vcdA-4lhuD:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2


(Homo sapiens)
PF00254
(FKBP_C)
5 PHE A  66
ASP A  67
VAL A  85
ILE A  86
TRP A  89
FK5  A 201 (-4.7A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.5A)
0.66A 2vcdA-4nnrA:
10.6
2vcdA-4nnrA:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2


(Homo sapiens)
PF00254
(FKBP_C)
5 PHE A  66
VAL A  85
ILE A  86
TRP A  89
TYR A 112
FK5  A 201 (-4.7A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.5A)
FK5  A 201 (-4.5A)
0.94A 2vcdA-4nnrA:
10.6
2vcdA-4nnrA:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  56
ASP A  67
VAL A  85
ILE A  86
TRP A  89
FK5  A 201 (-4.1A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.5A)
0.75A 2vcdA-4nnrA:
10.6
2vcdA-4nnrA:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnr PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP2


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  56
VAL A  85
ILE A  86
TRP A  89
TYR A 112
FK5  A 201 (-4.1A)
FK5  A 201 (-3.4A)
FK5  A 201 (-3.8A)
FK5  A 201 (-3.5A)
FK5  A 201 (-4.5A)
0.62A 2vcdA-4nnrA:
10.6
2vcdA-4nnrA:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p05 ARYLSULFATE
SULFOTRANSFERASE
ASST


(Escherichia
coli)
PF05935
(Arylsulfotrans)
PF17425
(Arylsulfotran_N)
5 TYR A 433
PHE A 429
ASP A 430
TYR A 473
VAL A 485
None
1.41A 2vcdA-4p05A:
undetectable
2vcdA-4p05A:
12.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
GLN A  85
VAL A  86
ILE A  87
TYR A 113
None
1.30A 2vcdA-4r0xA:
14.8
2vcdA-4r0xA:
30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
PHE A  67
VAL A  86
ILE A  87
TRP A  90
None
0.83A 2vcdA-4r0xA:
14.8
2vcdA-4r0xA:
30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4r0x PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5


(Homo sapiens)
PF00254
(FKBP_C)
5 TYR A  57
VAL A  86
ILE A  87
TRP A  90
TYR A 113
None
0.85A 2vcdA-4r0xA:
14.8
2vcdA-4r0xA:
30.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4txv CYTOCHROME C OXIDASE
SUBUNIT 2


(Bradyrhizobium
diazoefficiens)
PF00116
(COX2)
5 PHE B 156
VAL B 185
ILE B 135
TYR B 148
VAL B 256
None
1.46A 2vcdA-4txvB:
undetectable
2vcdA-4txvB:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u10 POLY-BETA-1,6-N-ACET
YL-D-GLUCOSAMINE
N-DEACETYLASE


(Aggregatibacter
actinomycetemcomitans)
PF01522
(Polysacc_deac_1)
5 TYR A 204
PHE A 212
GLN A 184
VAL A 176
VAL A 124
None
1.44A 2vcdA-4u10A:
undetectable
2vcdA-4u10A:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uoz BETA-GALACTOSIDASE

(Bifidobacterium
animalis)
PF02449
(Glyco_hydro_42)
PF08532
(Glyco_hydro_42M)
PF08533
(Glyco_hydro_42C)
5 PHE A 493
ASP A 469
VAL A 479
ILE A 476
VAL A 527
None
1.44A 2vcdA-4uozA:
undetectable
2vcdA-4uozA:
11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wgk NEUTRAL CERAMIDASE

(Homo sapiens)
PF04734
(Ceramidase_alk)
PF17048
(Ceramidse_alk_C)
5 TYR A 591
PHE A 456
ILE A 597
PRO A 450
VAL A 575
PO4  A 810 (-4.4A)
None
None
None
None
1.28A 2vcdA-4wgkA:
undetectable
2vcdA-4wgkA:
12.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zon VERRUCULOGEN
SYNTHASE


(Aspergillus
fumigatus)
PF05721
(PhyH)
5 TYR A 224
ASP A 131
PHE A 115
VAL A 221
PRO A 155
4Q1  A 401 (-3.6A)
FE2  A 402 ( 2.8A)
4Q1  A 401 (-3.8A)
None
None
1.31A 2vcdA-4zonA:
undetectable
2vcdA-4zonA:
19.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Coccidioides
immitis)
PF00254
(FKBP_C)
5 PHE C  55
ASP C  56
VAL C  73
ILE C  74
TRP C  77
FK5  C 201 ( 4.8A)
FK5  C 201 ( 3.8A)
FK5  C 201 (-3.5A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.4A)
0.73A 2vcdA-5b8iC:
12.8
2vcdA-5b8iC:
30.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Coccidioides
immitis)
PF00254
(FKBP_C)
5 PHE C  55
VAL C  73
ILE C  74
TRP C  77
TYR C 100
FK5  C 201 ( 4.8A)
FK5  C 201 (-3.5A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.4A)
FK5  C 201 (-4.5A)
0.92A 2vcdA-5b8iC:
12.8
2vcdA-5b8iC:
30.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Coccidioides
immitis)
PF00254
(FKBP_C)
5 TYR C  36
ASP C  56
VAL C  73
ILE C  74
TRP C  77
FK5  C 201 (-4.1A)
FK5  C 201 ( 3.8A)
FK5  C 201 (-3.5A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.4A)
0.86A 2vcdA-5b8iC:
12.8
2vcdA-5b8iC:
30.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b8i PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Coccidioides
immitis)
PF00254
(FKBP_C)
5 TYR C  36
VAL C  73
ILE C  74
TRP C  77
TYR C 100
FK5  C 201 (-4.1A)
FK5  C 201 (-3.5A)
FK5  C 201 (-3.8A)
FK5  C 201 (-3.4A)
FK5  C 201 (-4.5A)
0.68A 2vcdA-5b8iC:
12.8
2vcdA-5b8iC:
30.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bnd ABC TRANSPORTER,
ATP-BINDING PROTEIN


(Staphylococcus
epidermidis)
no annotation 5 PHE A 398
ILE A 463
PRO A 464
TRP A 500
TYR A 409
None
1.34A 2vcdA-5bndA:
undetectable
2vcdA-5bndA:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c54 DIHYDRODIPICOLINATE
SYNTHASE/N-ACETYLNEU
RAMINATE LYASE


(Corynebacterium
glutamicum)
PF00701
(DHDPS)
5 PHE A  44
PHE A 110
VAL A 144
ILE A 140
PRO A 141
None
1.43A 2vcdA-5c54A:
undetectable
2vcdA-5c54A:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5foh POLYSACCHARIDE
MONOOXYGENASE


(Neurospora
crassa)
PF03443
(Glyco_hydro_61)
5 PHE A 106
VAL A 173
ILE A 172
TYR A 143
VAL A  92
None
1.43A 2vcdA-5fohA:
undetectable
2vcdA-5fohA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gmt ALGINATE LYASE

(Aplysia kurodai)
no annotation 5 PHE A 172
GLN A 209
VAL A 202
ILE A 182
TYR A  85
None
1.44A 2vcdA-5gmtA:
undetectable
2vcdA-5gmtA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7p PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A


(Escherichia
coli;
Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  26
PHE A  36
ASP A  37
VAL A  55
ILE A  56
TRP A  59
TYR A  82
None
0.90A 2vcdA-5i7pA:
13.2
2vcdA-5i7pA:
26.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i7q PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A,FKBP-TYPE 16
KDA PEPTIDYL-PROLYL
CIS-TRANS
ISOMERASE,PEPTIDYL-P
ROLYL CIS-TRANS
ISOMERASE FKBP1A


(Escherichia
coli;
Homo sapiens)
PF00254
(FKBP_C)
7 TYR A  26
PHE A  36
ASP A  37
VAL A  55
ILE A  56
TRP A  59
TYR A  82
None
0.95A 2vcdA-5i7qA:
12.9
2vcdA-5i7qA:
28.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5i98 FK506-BINDING
PROTEIN 1


(Candida
albicans)
PF00254
(FKBP_C)
8 TYR A  30
PHE A  40
ASP A  41
GLN A  58
VAL A  59
ILE A  60
TRP A  63
TYR A  97
None
1.24A 2vcdA-5i98A:
13.5
2vcdA-5i98A:
35.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j6e FK506-BINDING
PROTEIN 1A


(Aspergillus
fumigatus)
PF00254
(FKBP_C)
7 TYR A  27
PHE A  37
ASP A  38
VAL A  56
ILE A  57
TRP A  60
TYR A  83
None
0.96A 2vcdA-5j6eA:
14.4
2vcdA-5j6eA:
30.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nju GENOME POLYPROTEIN

(Zika virus)
no annotation 5 TYR A 119
GLN A  98
VAL A  97
ILE A  94
PRO A  73
None
1.24A 2vcdA-5njuA:
undetectable
2vcdA-5njuA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tiz SULFOTRANSFERASE

(Schistosoma
japonicum)
no annotation 5 TYR A  47
GLN A  53
ILE A  41
TYR A  36
VAL A  85
None
1.44A 2vcdA-5tizA:
undetectable
2vcdA-5tizA:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tmh POLYPROTEIN

(Zika virus)
PF00972
(Flavi_NS5)
PF01728
(FtsJ)
5 TYR A 119
GLN A  98
VAL A  97
ILE A  94
PRO A  73
None
1.44A 2vcdA-5tmhA:
undetectable
2vcdA-5tmhA:
9.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v8t UBIQUITIN-LIKE
PROTEIN
SMT3,PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Burkholderia
pseudomallei;
Saccharomyces
cerevisiae)
no annotation 7 TYR A  33
PHE A  43
ASP A  44
VAL A  62
ILE A  63
TRP A  66
TYR A  89
8ZV  A 201 (-3.8A)
8ZV  A 201 (-4.8A)
8ZV  A 201 (-3.9A)
8ZV  A 201 (-3.6A)
8ZV  A 201 (-4.0A)
8ZV  A 201 (-3.3A)
8ZV  A 201 (-4.6A)
0.99A 2vcdA-5v8tA:
15.7
2vcdA-5v8tA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wka BETA-GLUCOSIDASE

(metagenome)
no annotation 5 ASP A  60
PHE A  96
GLN A  98
PRO A 113
TYR A  72
None
1.44A 2vcdA-5wkaA:
undetectable
2vcdA-5wkaA:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wrj PROTEIN-TYROSINE
SULFOTRANSFERASE 1


(Homo sapiens)
PF13469
(Sulfotransfer_3)
5 ASP A 185
GLN A 312
VAL A 310
ILE A 306
PRO A 307
None
1.37A 2vcdA-5wrjA:
undetectable
2vcdA-5wrjA:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wxi EARP

(Neisseria
meningitidis)
no annotation 5 ASP A 256
PHE A 362
GLN A 364
PRO A 368
VAL A  23
None
1.41A 2vcdA-5wxiA:
undetectable
2vcdA-5wxiA:
16.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xb0 PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE


(Pseudomonas
syringae group
genomosp. 3)
PF00254
(FKBP_C)
8 TYR A 147
PHE A 157
ASP A 158
PHE A 166
VAL A 171
ILE A 172
TRP A 175
TYR A 198
TLA  A 301 ( 4.4A)
None
TLA  A 301 (-3.7A)
TLA  A 301 ( 4.6A)
TLA  A 301 (-3.4A)
TLA  A 301 (-3.4A)
TLA  A 301 (-3.4A)
None
1.01A 2vcdA-5xb0A:
19.0
2vcdA-5xb0A:
40.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ybb RESTRICTION
ENDONUCLEASE S
SUBUNITS


(Caldanaerobacter
subterraneus)
no annotation 5 PHE D 252
ASP D 251
GLN D 267
ILE D 295
VAL D 279
None
1.23A 2vcdA-5ybbD:
undetectable
2vcdA-5ybbD:
17.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6b4p PEPTIDYLPROLYL
ISOMERASE


(Naegleria
fowleri)
no annotation 6 TYR A  38
PHE A  48
ASP A  49
VAL A  67
ILE A  68
TRP A  71
None
0.87A 2vcdA-6b4pA:
14.7
2vcdA-6b4pA:
32.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6b4p PEPTIDYLPROLYL
ISOMERASE


(Naegleria
fowleri)
no annotation 5 TYR A  38
VAL A  67
ILE A  68
TRP A  71
TYR A  94
None
0.82A 2vcdA-6b4pA:
14.7
2vcdA-6b4pA:
32.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fyd PUTATIVE
FAD-DEPENDENT
OXYGENASE ENCM


(Streptomyces
maritimus)
no annotation 5 PHE A 453
PHE A 204
VAL A 167
ILE A 169
VAL A  58
None
1.33A 2vcdA-6fydA:
undetectable
2vcdA-6fydA:
19.71